Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tampa, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Akari Therapeutics Plc has filed 726 SEC EDGAR filings since 13 Apr 2012

SEC filing history

Showing 626-650 of 726 matching filings.

Per page
25
Current page
26
424B2 File 333-198107

RULE 424(B)(2)

Filing date
27 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-198107

EFFECT filing

Filing date
20 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-198109

FORM S-8

Filing date
13 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3 File 333-198107

FORM F-3

Filing date
13 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
24 Jun 2014
Reporting date
19 Jun 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

6-K

Filing date
12 May 2014
Reporting date
12 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Apr 2014
Reporting date
06 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2014
Reporting date
14 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2014
Reporting date
09 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2014
Reporting date
04 Apr 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-191880

RULE 424(B)(3)

Filing date
07 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-187826

RULE 424(B)(3)

Filing date
07 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-185247

RULE 424(B)(3)

Filing date
07 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
20-F/A File 001-36288

FORM 20-F/A

Filing date
07 Apr 2014
Reporting date
31 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Apr 2014
Reporting date
31 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-191880

EFFECT filing

Filing date
31 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-187826

EFFECT filing

Filing date
31 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-185247

EFFECT filing

Filing date
31 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36288

REPORT OF FOREIGN PRIVATE ISSUER

Filing date
31 Mar 2014
Reporting date
28 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Mar 2014
Reporting date
25 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Mar 2014
Reporting date
20 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
14 Mar 2014
Reporting date
06 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-191880

POS AM

Filing date
13 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-187826

POS AM

Filing date
13 Mar 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .